MEMS Education Series™: Spotlight on BioMEMS and NanoMedicine
Make new connections with the biomedical community: including CEOs, clinicians, researchers and the FDA
Hear how and where MEMS fits into biomedicine and where the near-term growth opportunities are
Learn about commercialization challenges from the research/startup phase to the end-customer
Gain an understanding of FDA hurdles and how the federal regulation system of biomedicine works
Imagine the elimination of cancer through early detection, implantable Personal Molecular Drug-delivery Systems (PMDS) that increase therapeutic efficacy and reduce adverse side-effects, or healing fractures using a degradable nanopourous silicon putty. These are only some of the projects that researchers at the Department of NanoMedicine and Biomedical Engineering (nBME) at the University of Texas Health Science Center are working on everyday to advance healthcare and improve quality of life.
Collaboration with the biomedical community can open up tremendous opportunities for the MEMS industry. To foster this goal, MEMS Industry Group (MIG) is offering this one-day executive education workshop at the nBME facilities in Houston.
Who should attend?
This education focused-workshop is for MEMS industry executives seeking to explore new opportunities in bio and nanomedicine. This workshop is open industry-wide, but MIG members receive a deep discount on registration. For details on the benefits of membership visit www.memsindustrygroup.org/membership.
The aim is to facilitate networking between technologists and executives in the biomedical field and the MEMS industry in order to create more opportunities for commercialization of MEMS technology.
Schedule (subject to change):
Morning
Shuttle pick-up attendees from Hilton
6:45 AM
Breakfast
7:00 AM
Opening Keynote - Mauro Ferrari, Ph.D.- Professor and Chairman, Department of Nanomedicine and Biomedical Engineering (nBME)
Dr. Ferrari will expand upon his keynote address"Silicon as a Medical Material" from MEMS Executive Congress 2009.
8:00 AM
Randy Goodall- President and CEO, Nanomedical Systems, Inc.
8:30 AM
Larry Cooper, M.D., Ph.D.- Associate Professor, Pediatric Cell Therapy Service, UTMDACC
8:45 AM
Bradley Weiner, M.D.- Associate Professor, Director, Spine Advanced Technology Lab, The Methodist Hospital
9:00 AM
Jason Sakamoto, Ph.D.- Chief Operating Officer, Alliance for Nanohealth
9:15 AM
Clinical, Commercialization, and Regulatory Panel Discussion
The Department of NanoMedicine and Biomedical Engineering (nBME) at The University of Texas Health Science Center at Houston is a research department that combines nano-engineering, mathematical modeling and biomedical sciences to develop nanotechnology enabled therapeutic and diagnostic platforms for combating diseases including cancer, cardiovascular diseases and infectious diseases.
nBME is run under the leadership of Dr. Mauro Ferrari, a visionary in the field of biomedicine often referred to as the "father of BioMEMS." In addition to being Professor and Chairman of nBME, Dr. Ferrari is a Professor of Experimental Therapeutics at The University of Texas M.D. Anderson Cancer Center and a Professor of Bioengineering at Rice University. He is also the President of Alliance for NanoHealth.
Dr. Mauro Ferrari, Professor and Chairman of nBME
Furthermore, he is the scientific founder of NanoMedical Systems and Leonardo Biosystems. He also currently serves as the Director of Scientific Strategy at the Arrowhead Research Corporation.
.jpg)
.jpg)
